Herceptin (Trastuzumab) in Treating Women With Human Epidermal Growth Factor Receptor (HER) 2-Positive Primary Breast Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Karen A. Gelmon, MD
British Columbia Cancer Agency
Study Chair - Kathleen I. Pritchard, MD
Toronto Sunnybrook Regional Cancer Centre
Study Chair - Martine J. Piccart-Gebhart, MD, PhD
Jules Bordet Institute
Study Chair - Olivia Pagani, MD
Ospedale Beata Vergine
Study Chair - Robert E. Coleman, MD, FRCP
Cancer Research Centre at Weston Park Hospital
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
203 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hospital Aleman de Buenos Aires
Buenos Aires, Buenos Aires, Argentina
- Saint John of God Hospital
Geelong, Australian Capital Territory, Australia
- Toowoomba Hospital
Toowoomba, Queensland, Australia
- Andrew Love Cancer Centre
Geelong, Victoria, Australia
- Mount Hospital
Perth, Western Australia, Australia
- Landeskrankenhaus Feldkirch
Feldkirch-Tisis, Austria
- Innsbruck Universitaetsklinik
Innsbruck, Austria
- Landeskrankenhaus Klagenfurt
Klagenfurt, Austria
- St. Vincent'S Hospital
Linz Donau, Austria
- Landeskrankenanstalten - Salzburg
Salzburg, Austria
- Landeskrankenhaus St. Poelten
Sankt Pölten, Austria
- Universitaetsklinik Fuer Innere Medizin I
Vienna, Austria
- Wilhelminenspital Der Stadt Wien
Vienna, Austria
- Lkh Villach
Villach, Austria
- Lkh Voecklabruck
Vöcklabruck, Austria
- A. Oe. Krankenhaus Wiener Neustadt
Wiener Neustadt, Austria
- Ziekenhuis Netwerk Antwerpen Middelheim
Antwerp, Belgium
- Reseau Hospitalier de Medecine Sociale
Baudour, Belgium
- Academisch Ziekenhuis Der Vrije Universiteit Brussel
Brussels, Belgium
- Hopital Universitaire Erasme
Brussels, Belgium
- Institut Jules Bordet
Brussels, Belgium
- Centre Hospitalier Notre Dame - Reine Fabiola
Charleroi, Belgium
- Cazk Groeninghe - Campus St-Niklaas
Kortrijk, Belgium
- Centre Hospitalier Universitaire de Tivoli
La Louvière, Belgium
- U.Z. Gasthuisberg
Leuven, Belgium
- Chu Liege - Domaine Universitaire Du Sart Tilman
Liège, Belgium
- Clinique Saint-Joseph
Liège, Belgium
- Clinique Sainte Elisabeth
Namur, Belgium
- Hospital Serruys Ziekenhuis
Ostend, Belgium
- Centre Hospitalier Peltzer-la Tourelle
Verviers, Belgium
- Porto Alegre Hospital
Porto Alegre, Rio Grande do Sul, Brazil
- Hospital Santa Rita
Porto Alegre, Brazil
- Hospital Sao Lucas Da Pucrs
Porto Alegre, Brazil
- Instituto Nacional de Cancer
Rio de Janeiro, Brazil
- Faculdade de Medicina Do Abc
Santo André, Brazil
- Tom Baker Cancer Centre - Calgary
Calgary, Alberta, Canada
- British Columbia Cancer Agency - Centre for the Southern Interior
Kelowna, British Columbia, Canada
- Fraser Valley Cancer Centre at British Columbia Cancer Agency
Surrey, British Columbia, Canada
- British Columbia Cancer Agency - Vancouver Cancer Centre
Vancouver, British Columbia, Canada
- British Columbia Cancer Agency - Vancouver Island Cancer Centre
Victoria, British Columbia, Canada
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2001
- Primary completion
- 31 Mar 2005
- Completion
- 30 Jun 2015
- Last update posted
- 27 Apr 2017
- Registered enrollment
- 5,099
- Registry id
- NCT00045032
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.